ANTIMICROBIAL PROFILE OF SALMONELLA SPECIES ISOLATED AT TERTIARY CARE HOSPITAL WESTERN INDIA
HTML Full TextANTIMICROBIAL PROFILE OF SALMONELLA SPECIES ISOLATED AT TERTIARY CARE HOSPITAL WESTERN INDIA
Sonia Barve, Sandeep Nanda, Arpita Parmar * and Gopal Koli
Department of Microbiology, Medical College Baroda & SSG Hospital, Vadodara, Gujarat, India.
ABSTRACT: Background & Objective: India is home to two infectious diseases caused by Salmonella: typhoid and paratyphoid fever. The medication of choice for S. typhi is ceftriaxone, a third-generation cephalosporin. Study was carried out on the Surveillance of Enteric Fever in India to ascertain the prevalence, clinical manifestation, and trajectory of antimicrobial resistance (AMR). This work aimed to examine the antibiogram profiles of Salmonella typhi found in patient blood cultures. Second, to record how often Salmonella typhi infections occur located in Vadodara, the Antibiotic Susceptibility Test is third. Material and Methods: The Retrospective study was carried out over a period of 12 months after obtaining ethical approval. The freshly drawn venous blood was placed in a blood culture vial. Following identification of pathogen isolates, Kirby-Bauer disc diffusion test was employed to determine antibiotic drug susceptibility as per CLSI rules. Results: Total 10,126 blood samples were collected. In 84 samples (0.83%), 83 instances of Salmonella typhi and 1 instance of Para typhi B. The ratio of males to females was 1:2. Children aged 0–14 years had greater incidence of enteric fever. From July to September, the most instances are solitary. The majority of the Salmonella typhi isolates showed resistance to Ceftriaxone but were sensitive to Ciprofloxacin, Azithromycin and Cotrimoxazole. Conclusion: It has been shown in this review that antibiotic resistance is on the rise among Salmonella species. The use of empirical treatment for enteric fevers should be avoided in favor
Keywords: Antimicrobial susceptibility, Enteric fever, Salmonella, Antimicrobial resistance
INTRODUCTION: Typhoid fever is caused by the gram-negative rod-shaped Enterobacteriaceae family member Salmonella typhi, which can enter bloodstream and cause a potentially deadly illness. It has been a major contributor to illness and death in underdeveloped countries. Compared to South Asian and African nations with low or medium incomes, developed nations have a far lower typhoid incidence rate 1. With an estimated 9.25 million cases in 2019, the majority of the 110,000 fatalities caused by typhoid fever were in South Asia and Sub-Saharan Africa, according to the Global Burden of Disease Study 2. S. typhi is a human-only pathogen in the wild, and contamination of food or water is the usual vector for its transmission. There were two deaths, and eighty-eight cases reported in the Malaysian province of Kelantan in 2005 3.
Following consuming food or water contaminated with S. typhi, symptoms often appear 7–14 days following the asymptomatic phase. After the first asymptomatic period, patients may have gastrointestinal discomfort, nausea, vomiting, and diarrhea. The severity and quantity of mortality caused by several infectious illnesses have been greatly reduced thanks to antibiotics having been an essential weapon in the fight against typhoid 4, 5. The overuse and abuse of antibiotics in human therapy has unfortunately led to an increase in the resistance of S. typhi to these medications. On their own, mutations in Salmonella typhi can cause the development of AMR 6, 7. Current antimicrobial resistance (AMR) data for S. typhi is essential for effective antibiotic stewardship and better patient outcomes, and this data should be accessible worldwide and in real-time. Consequently, this study used a systematic review and meta-analysis to assess the frequency of AMR in S. typhi isolated from people.
MATERIALS AND METHODS: “Researchers from Medical College Baroda's Microbiology Department in Vadodara, Gujarat, carried out a retrospective study from January to December 2023.A venous blood sample was obtained from patients exhibiting typhoid-like symptoms, regardless of whether they were hospitalized or not (5 mL for adults and 2 mL for children). The venous blood samples that were taken were transferred using blood culture sterile vials, which can be either the classic or Bactec variety (Adult & Pediatric). The first culture is carried out in a standard blood culture bottle following a 24-hour incubation period in a carbon dioxide incubator. In addition, we accurately label the blood vial so that the Bactec machine can recognize the development. Bacteria that demonstrated growth were then transferred to several medium, including MacConkey agar, xylose lysine deoxycholate (XLD) agar, and Salmonella-shigella (SS), after being incubated at 370C for 18-20 hours. The isolates were characterized using colony morphology and biochemicaltests. The use of antisera allowed for the confirmation of S. typhi or Para typhi instances. Antibiotic susceptibility testing, which included the modified Kirby-Bauer disc diffusion method, was conducted in accordance with CLSI criteria 8. Equally spaced were the Mueller-Hinton agar plates that had been impregnated. The following antimicrobial discs were applied to the plates using sterile forceps: the following dosages of antibiotics: ampicillin (10 micrograms), ceftriaxone (30 micrograms), azithromycin (15 micrograms), doxycycline (30 micrograms), imipenem (30 micrograms), ciprofloxacin (5 micrograms), chloramphenicol (30 micrograms), and co-trimoxazole (1.25/23.75 micrograms). The discs were 6 mm from the edge and 10-15 mm apart. For the purpose of quality control, we utilized ATCC strains (ATCC-27853 for Pseudomonas aeruginosa, ATCC-25923 for Staphylococcus aureus, and ATCC-25922 for Escherichia coli).
FIG. 1: MALONATE TEST
FIG. 2: ANTIBIOTIC SUSCEPTIBILITY TEST
FIG. 3: SALMONELLA ANTISERA TEST
FIG. 4: INDOLE TEST
FIG. 5: TRIPLE SUGAR IRON TEST
Inclusion Criteria: If a patient has septicemia symptoms such as a high temperature, shortness of breath, low blood pressure, rapid heart rate, mental disorientation, or decreased urine output, medical attention is needed immediately.
RESULTS: The study included 84 patients, with 39 being males and 45 being females, for a male to female ratio of approximately 1:1.2. The age range of 0-14 years comprised the majority of the Salmonella cases (n=54). Below, you can find the age distribution of the Salmonella cases in Fig. 6 and the gender distribution in chart 2. As per Fig. 7 of Age wise distribution of salmonella showed that in children under 14 year (n=54) old age group a greater number of salmonella were isolated. One third number of Salmonella were isolated in more than 14 year of age (n=30) children and adult. As per above chart 2 of Gender wise distribution of salmonella shown that there is no major difference between Male and Female Gender.
FIG. 6: AGE WISE DISTRIBUTION
FIG. 7: GENDERWISE DISTRIBUTION
FIG. 8: MONTHWISE DISTRIBUTION
In this study, the rate of typhoid fever was varied during the year time. In this study as shown in Table no 1 highest number of cases were isolated from July (26 cases) followed by August & September (10 cases). Also 1 cases of Salmonella Para typhi B was isolated in October. A total of 57 cases were isolated in summer, monsoon and post monsoon season.
TABLE 1: ANTIBIOGRAM OF SALMONELLA TYPHI (N=83)
Antibiotic | Susceptible | Resistant | Intermediate |
Ampicillin (10 μg) | 67 % (n=54) | 32% (n=26) | 1% (n=3) |
Ceftriaxone (30 μg) | 79% (n=66) | 17 % (n=14) | 4% (n=3) |
Azithromycin (15 ug) | 71.08% (n=59) | 28.92 % (n=24) | - |
Doxycycline (30 μg) | 65.06% (n=54) | 30.12 % (n=25) | 4.81 (n=4) |
Ciprofloxacin (5 μg) | 10 % (n=9) | 71 % (n=59) | 19% (n=15) |
Co-Trimoxazole (1.25/23.75 μg) | 70 % (n=59) | 25 % (n=21) | 5% (n=3) |
In present study 79% susceptibility to ceftriaxone was found followed by, 71.08% to Azithromycin, 70% to cotrimoxazole, 67% to ampicillin, 65.06% to doxycycline and 10% to ciprofloxacin. 14 cases resistance to third-generation cephalosporins (Ceftriaxone 30 μg) is the most worrisome finding in this study. Imipenem susceptibility testing is done by disc diffusion method in isolates were observed Ceftriaxone resistant. One case of Salmonella Para typhi B was isolated and it was fully susceptible to all antibiotic drugs.
DISCUSSION: Enteric fever is primarily caused by Salmonella typhi. Antimicrobial susceptibility patterns have been found to be changing throughout several regions of India, highlighting the need for ongoing evaluation and monitoring 9.
In the present study, out of the total 84casesof typhoid and paratyphoid cases are observed with majority almost 98% being typhoid fever. These findings were similar to study done by Patil et al 10, Mishra et al 11 and Khadaka et al 12 all reported that S. typhi is major isolates followed by S. Para typhi A. Patients in rural areas were more likely to have poor faeco-oral hygiene and water sanitation, which is why the majority of Salmonella isolates came from those areas. Patients in rural areas were more likely to have poor faeco-oral hygiene and water sanitation, which is why the majority of Salmonella isolates came from those areas 9.
Typhoid fever cases highest number in below 14 year of age group which is differ from Al-Roubaea et al.13 study which represent maximum number of salmonella cases isolates in 21-30 year. The reason for which may be because enteric fever is endemic in India.
There was no significant difference between the sexes when looking at the gender distribution of Salmonella spp. This result agreed with what Jaafar et al. found in their previous research 14.
In this study that the highest number of cases with enteric fever (54.76%) are in monsoon months like July, August and September which is similar to Al khafaji et al 15 study that observed highest number (65.53%) of patients with typhoid fever in Summer and monsoon months. Consistent with previous research, the current study found that nearly all Salmonella typhi isolates were sensitive to cephalosporins, with a particularly high percentage (79%) to Ceftriaxone Patil et al 10 is completely susceptible to ceftriaxone, as has been observed in comparable studies.
Present study has 71% susceptibility to Azithromycin and similar findings are observed by Chayani et al 16 83% and different findings were noted by Patel SR et al 17 and Jain et al 18 study that 21% & 7% susceptibility to Azithromycin respectively (2011-2013).
Jain et al 18 study has noted the 19.1% susceptibility to cotrimoxazole which was lower than present study (70%).
Medella et al 19 showed decreased susceptibility towards the FQs mainly ciprofloxacin that was0.6% that was similar to present study susceptibility that was 10%
In this present study show en that total 14 cases resistance to third-generation Cephalosporins (Ceftriaxone 30 μg) which like as Farah Naz Qamar et al 20. Study in which two cases of resistance to third-generation Cephalosporins Ceftriaxone. For all isolated, that is Ceftriaxone resistant, Imipenem susceptibility testing is done by disc diffusion method and all the isolates were observed to susceptible 21.
So, Evaluation of susceptibility data of various antibiotic drug is made there is constant increase in resistance of ceftriaxone pattern. Therefore, it is important to monitor the changes in susceptibility pattern over the years.
Limitation: Although Quality Control was done regularly, AMR pattern of S. typhi is done by disc diffusion method, for confirmation of Cetriaxone resistance better method like Broth Microdilution or Gene Sequencing is required.
Treatment given & Outcome of the patients was not captured in this study.
CONCLUSION: It has been shown in this review that antibiotic resistance is on the rise among Salmonella species. The use of empirical treatment for enteric fevers should be avoided in favour of third generation cephalosporins, Cefepime, Carbapenem, and azithromycin.
ACKNOWLEDGEMENT: None
CONFLICTS OF INTEREST: None
REFERENCES:
- Bhandari J, Thada PK and DeVos E: Typhoid Fever. National Library of Medicine 2022.
- The Lancet Global Health. A bright future in typhoid vaccines. Lancet Glob. Health 2021; 9(12): 1623.
- Ahmad Faris AN, Ahmad Najib M, Mohd Nazri MN, Hamzah ASA, Aziah I and Yusof NY: Colorimetric Approach for Nucleic Acid Salmonella Detection: A Systematic Review. International Journal of Environmental Research and Public Health 2022; 19(17): 10570.
- Crump JA, Sjölund-Karlsson M, Gordon MA and Parry CM: Epidemiology, clinical presentation, laboratory diagnosis, antimicrobial resistance, and antimicrobial management of invasive salmonella infections. Clin Microbiol Rev 2015; 28(4): 901-37.
- Mohd Asri NA, Ahmad S, Mohamud R, Mohd Hanafi N, Mohd Zaidi NF, Irekeola AA, Shueb RH, Yee LC, Mohd Noor N, Mustafa FH, Yean CY and Yusof NY: Global Prevalence of Nosocomial Multidrug-Resistant Klebsiella pneumoniae: A Systematic Review and Meta-Analysis. Antibiotics (Basel) 2021; 10(12): 1508.
- Ramatla T, Tawana M, Onyiche TE, Lekota KE and Thekisoe O: Prevalence of Antibiotic Resistance in Salmonella Serotypes Concurrently Isolated from the Environment, Animals, and Humans in South Africa: A Systematic Review and Meta-Analysis. Antibiotics (Basel) 2021; 10(12): 1435.
- Ventola CL: The antibiotic resistance crisis: part 1: causes and threats. P T 2015; 40(4): 277-83.
- Clinical Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing (Twenty-Fourth Informational Supplement. CLSI document M100-S24). Wayne, PA: Clinical and Laboratory Standards Institute 2024; 50–57.
- Kanungo S, Dutta S and Sur D: Epidemiology of typhoid and paratyphoid fever in India. J Infect Dev Ctries 2008; 2(6): 454-60.
- Patil N and Mule P: Sensitivity pattern of Salmonella typhi and Paratyphi a isolates to chloramphenicol and other anti-typhoid drugs: an in-vitro Infect Drug Resist 2019; 12: 3217-3225.
- Misra R and Prasad KN: Antimicrobial susceptibility to azithromycin among Salmonella enterica Typhi and Paratyphi A isolates from India. J Med Microbiol 2016; 65(12): 1536-1539.
- Khadaka P, Thapaliya J and Thapa S: Susceptibility pattern of Salmonella enterica against commonly prescribed antibiotics, to febrile-pediatric cases, in low-income countries. BMC Pediatr 2021; 21: 38.
- Al Roueaba DA, Al-ani AA and Al Shaker NMM: Value of widal test in diagnosis of typhoid fever. Iraqi J Comm Med 2008; 21(1): 13-18.
- Jaafar NJ, Yuan XG, Nur FMZ, Heng CL, Hani MH, Wan MH and Kia KP: Epidemiological analysis of typhoid fever in Kelantan from a retrieved registry. Malay J Microbiol 2013; 9(2): 147-151.
- Al-Khafaji and Jawad: Prevalence of Typhoid Fever among Pediatric Patients at AL-Musaib District. Medical Journal of Babylon 2006; 3(2): 75-80.
- Chayani N, Tiwari S and Sarangi G: Role of azithromycin against clinical isolates of family enterobacteriaceae: a comparison of its minimum inhibitory concentration by three different methods. Indian J Med Microbiol 2009; 27(2): 107–110.
- Patel SR, Bharti S, Pratap CB and Nath G: Drug resistance pattern in the recent isolates of Salmonella typhi with special reference to cephalosporins and azithromycin in the gangetic plain. J Clin Diagn Res 2017; 11(6): 01-03.
- Jain S and Das Chugh T: Antimicrobial resistance among blood culture isolates of Salmonella enterica in New Delhi. J Infect Dev Ctries 2013; 7(11): 788-95.
- Medalla F, Sjölund-Karlsson M, Shin S, Harvey E, Joyce K, Theobald L, Nygren BN, Pecic G, Gay K, Austin J, Stuart A, Blanton E, Mintz ED, Whichard JM and Barzilay EJ: Ciprofloxacin-resistant Salmonella enterica Serotype Typhi, United States, 1999-2008. Emerg Infect Dis 2011; 17(6): 1095-98.
- Farah Naz Q, Asma A, Abdul MK, Erum K and Anita KZ: A three-year review of antimicrobial resistance of Salmonella enterica serovars Typhi and Paratyphi A in Pakistan. J Infect Dev Ctries 2014; 8(8): 981-986.
- The National Institute of Communicable Diseases (NICD).
How to cite this article:
Barve S, Nanda S, Parmar A and Koli G: Antimicrobial profile of Salmonella species isolated at Tertiary Care Hospital Western India. Int J Pharm Sci & Res 2025; 16(5): 1403-08. doi: 10.13040/IJPSR.0975-8232.16(5).1403-08.
All © 2025 are reserved by International Journal of Pharmaceutical Sciences and Research. This Journal licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License.
Article Information
27
1403-1408
1190 KB
24
English
IJPSR
Sonia Barve, Sandeep Nanda, Arpita Parmar * and Gopal Koli
Department of Microbiology, Medical College Baroda & SSG Hospital, Vadodara, Gujarat, India.
arpita95parmar@gmail.com
03 December 2024
21 December 2024
28 December 2024
10.13040/IJPSR.0975-8232.16(5).1403-08
01 May 2025